StockNews.com Initiates Coverage on MediciNova (NASDAQ:MNOV)

Analysts at StockNews.com began coverage on shares of MediciNova (NASDAQ:MNOV – Get Free Report) in a research report issued on Sunday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. MediciNova Stock Performance NASDAQ:MNOV opened at $2.38 on Friday. MediciNova has a fifty-two week low of $1.12 and a fifty-two week high of […]

Leave a Reply

Your email address will not be published.

Previous post GlycoMimetics (NASDAQ:GLYC) Research Coverage Started at StockNews.com
Next post Roxgold (OTCMKTS:ROGFF) Shares Up 2% – What’s Next?